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Here, we studied in vitro cytokine production by splenic macrophages obtained from young and aged BALB/c wild type (WT) and
IL-6knockout(IL-6KO)mice.RelativetomacrophagesobtainedfromyoungWTmicegivenlipopolysaccharide(LPS),thosefrom
aged WT mice had decreased production of proinﬂammatory cytokines. In contrast, when compared to macrophages from young
IL-6 KO mice, LPS stimulation yielded higher levels of these cytokines by cells from aged IL-6 KO mice. Aging or IL-6 deﬁciency
did not aﬀected the percentage of F4/80+ macrophages, or the surface expression of Toll-like receptor 4 (TLR4) and components
of the IL-6 receptor. Overall, our results indicate that IL-6 plays a role in regulating the age-related defects in macrophages through
alteration of proinﬂammatory cytokines, adding to the complexity of IL-6-mediated impairment of immune cell function with
increasing age.
1.Introduction
As a part of the age-associated deterioration of the immune
system [1–3], there is a chronic proinﬂammatory state even
in the absence of clinically-apparent disease. This state
deﬁned as “inﬂamm-aging” is characterized by elevated
circulating levels of proinﬂammatory factors (IL-1β,I L -
6, TNFα, and prostaglandin E2) and anti-inﬂammatory
mediators, (IL-1 receptor antagonist, soluble TNF receptor,
IL-10,transforminggrowthfactorbeta,acutephaseproteins,
C-reactive protein, and serum amyloid A) and contributes to
the decreased ability of the elderly to mount an appropriate
immune response following an infectious challenge [4–7].
One of the most prominent aspects of “inﬂamm-
aging” is in presence of elevated circulating levels of the
proinﬂammatory cytokine, interleukin (IL)-6 [8, 9]. In an
attempt to better deﬁne the role of IL-6 in the systemic
inﬂammatory response in the aged, we gave young and aged
wild type (WT) and IL-6 knockout (KO) BALB/c female
mice lipopolysaccharide (LPS). Following the inﬂammatory
challenge, aged IL-6 KO mice had improved survival when
compared to aged WT mice [10]. Moreover, we previously
reported that aged IL-6 KO mice showed a decreased acute
phase response when compared to that of aged WT mice
[10]. In addition, hepatic injury was drastically reduced in
aged IL-6 KO mice given LPS as compared with LPS-exposed
aged WT mice [11]. Recently, Starr et al. reported similar
ﬁndingsinmaleC57BL/6IL-6KOmiceusingahigherdoseof
LPS (5mg/kg) and a slightly older group of mice (26 months
old) [12] than our study. Taken together, these observations
have suggested a crucial role for IL-6 as a component of the
aberrant systemic innate immune responses of the aged after
an inﬂammatory challenge or injury and that this role is not
sex or strain speciﬁc.
Macrophages play critical roles in phagocytosis of anti-
gens,microorganisms, andcellulardebris; killing of invading2 Mediators of Inﬂammation
pathogens and tumors; and wound healing [13]. Many of the
macrophage functions are carried out by secreted cytokines,
which in turn, regulate multiple immune functions, espe-
cially inﬂammatory responses [14]. The eﬀects of aging on
cytokine production by macrophages have shown conﬂicting
results with in vitro stimulation of puriﬁed macrophage
populations with LPS and in vivo systemic administration of
LPS. For example, our laboratory and others reported that
macrophages from aged mice produce less TNFα and IL-6
after in vitro exposure to LPS than comparably stimulated
cells from young mice [15–19]. These ﬁndings have been
observed despite the presence of “inﬂamm-aging” and the
elevated baseline inﬂammatory state seen in healthy aged
individuals [20, 21].
Since macrophages are considered to be an important
source of proinﬂammatory cytokines in vivo,m a n yp o s -
sible explanations for this inconsistency can be proposed
[22]. Among the multiple possibilities, the eﬀect of the
local environment in vitro versus the eﬀect of the aged
microenvironment in vivo has been considered [22–24]. We
reported that serum from aged Fisher 344 rats increased
the levels of IL-6 by macrophages obtained from young
animals and cultured in vitro without stimulants [25].
These observations suggest that the elevated production of
inﬂammatory mediators in the aged results, in part, from the
interaction of macrophages with a variety of factors in their
environment in situ.
To analyze the role that IL-6 might play in regulat-
ing the age-related defects in macrophages through alter-
ation of proinﬂammatory cytokines, we exposed splenic
macrophages from young and aged WT and IL-6 KO
mice to LPS. Our ﬁndings suggest that IL-6 regulates the
age-related defects in macrophages through alteration of
proinﬂammatory cytokines and that these alterations are not
due to changes in surface expression of TLR4 or the IL-6
receptor.
2.MaterialsandMethods
2.1. Animals. Young (2 months old) and aged (18 months
old) WT female BALB/c mice were purchased from the
National Institute of Aging colony at Harlan Laboratories
(Indianapolis, IN). IL-6 KO mice, kindly provided by
Dr. Manfred Kopf, Molecular Biomedicine, ETH Zurich,
Switzerland, have a disruption of IL-6 in the second exon
(ﬁrst coding exon) by insertion of a neor cassette [26]. IL-
6KO mice were backcrossed onto the BALB/c background,
bred, maintained, and aged at the Taconic Laboratories
(Germantown, NY). Young (2 months old) and aged (18
months old) female BALB/c IL-6 KO mice were used
in the experiments described here. Animals were housed
under similar conditions at their respective facilities. They
were free of potential endemic viral pathogens that could
inﬂuence their inﬂammatory response. All animals where
maintained in an environmentally controlled facility at
Loyola University Medical Center for at least one week
prior to experimentation. At the time of sacriﬁce, all mice
were dissected and the organs were screened for visible
tumors and/or gross abnormalities. If found, these animals
were removed from the study. The experimental protocols
described here followed the guidelines established by the
publication, Principles of Laboratory Animal Care (NIH
publication no. 86–23, revised 1985), and were approved by
the Loyola University Chicago Institutional Animal Care and
Use Committee.
2.2. Cell Isolation and Culture. Mice were sacriﬁced by
CO2 inhalation and subsequent cervical dislocation. In
order to avoid confounding factors related to circadian
rhythms, all animal protects were performed between 8
and 9 AM. Splenic macrophages were isolated by plastic
adherence as previously described [17]. Brieﬂy, spleens were
aseptically removed and disrupted to yield a cell suspen-
sion in RPMI 1640 medium, supplemented with 5% FBS,
penicillin (100U/ml), streptomycin (100μg/ml), and 2mM
glutamine (culture medium) (GIBCO-BRL, Grand Island,
NY). Following red blood cell lysis with ACK Lysis Buﬀer
(Invitrogen Corp., Carlsbad, CA), white blood cells were
countedinahemocytometerandviabilitywasdeterminedby
TrypanBlueexclusion.Two ×106 cellswereseededin96-well
plates in 200μl culture medium. After incubation for 2 hours
at 37
◦C and 5% CO2, nonadherent cells were discarded by
medium aspiration and washed twice with warm phosphate
buﬀer saline (PBS). This method resulted in an adherent
populationcharacterizedas>98%positiveforMac-3andDi-
I-acetylated low-density lipoprotein uptake, as we previously
reported [27] .A d h e r e n tc e l l sw e r et r e a t e di n2 0 0μlc u l t u r e
mediumaloneorcontaining100ng/mlLPSfromEscherichia
coli 0111:B4 (Sigma Biosciences, St. Louis, MO). In the
absence of stimulation, macrophage cytokine levels were
undetectable ([16] and data not shown). Supernatants were
collected after 16 hours and stored at −80
◦C.
2.3. Measurement of Proinﬂammatory Cytokines. The con-
centrations of TNFα,I L - 1 β, IL-6, and IL-12 in macrophage
supernatants were measured by commercially available
OptEIA ELISAkits (BDPharmingen,SanDiego,CA) accord-
ing to the manufacturer instructions. The lowest detectable
limit of these kits is 15.6pg/ml. Data are expressed as pg/ml.
2.4. Flow Cytometry. Total spleen cell suspensions were
o b t a i n e da sr e p o r t e da b o v e .F l o wc y t o m e t r yw a sp e r f o r m e d
as previously described [16, 17]. Brieﬂy, after blocking
nonspeciﬁc staining with anti-CD16/CD32 (FcγIII/II; BD-
PharMingen, San Diego, CA), total splenocyte suspensions
were stained with APC-conjugated anti-CD3 (0.25μg/1 ×
106 cells, clone 145-2C11, eBioscience, San Diego, CA), PE-
conjugated anti-CD4 (0.125μg/1 × 106 cells, clone GK1.5,
eBioscience, San Diego, CA), FITC-conjugated anti-CD8
(0.5μg/1 × 106 cells, clone 53–6.7, eBioscience, San Diego,
CA), FITC-conjugated anti-Ly49c (0.5μg/1 × 106 cells,
clone 5E6, eBioscience, San Diego, CA), Alexa ﬂuor 750-
conjugated anti-F4/80 (0.1μg/1×106 cells, clone BM8, Invit-
rogen Corp., Camarillo, CA), PE-conjugated anti-IL-6Ra
(0.06μg/1 × 106 cells, clone D7715A7, BD-PharMingen, San
Diego, CA), APC-conjugated anti-CD19 (0.5μg/1×106 cells,Mediators of Inﬂammation 3
clone MB 19–1, eBioscience, San Diego, CA), and biotin-
conjugated anti-TLR4 (0.25μg/1 × 106 cells, clone MTS510,
eBioscience, San Diego, CA), biotin-conjugated anti-gp130
(1μg/1 × 106 cells, clone 125623, R&D Systems Inc.,
Minneapolis, MN). Following biotin-conjugate incubation,
cells were incubated with PerCP-conjugated streptavidin
(0.125μg/1 × 106 cells, eBioscience, San Diego, CA). Flow
cytometric determinations were made using Becton Dickin-
son FACSCanto ﬂow cytometer (BDIS, San Jose, CA) and
data was analyzed with FlowJo software (Tree Star Inc.,
Ashland, OR).
2.5. Statistical Analysis. Data are expressed as mean ± SEM.
ANOVA and Tukey-Kramer Multiple Comparisons were
used to determine statistical signiﬁcance using GraphPad
Prism Version 2.0 statistical package (San Diego, CA, USA).
A P value less than .05 was considered signiﬁcant.
3. Results
3.1. Cytokine Levels in Macrophages from Aged IL-6-Deﬁcient
Mice after LPS Stimulation. When stimulated in vitro with
LPS, macrophages from aged mice produce less cytokines
than comparably stimulated cells from young mice [15–19].
To determine if this phenotype may be determined in part
by IL-6, which is elevated in the circulation of healthy aged
individuals [9, 10, 28, 29], we evaluated proinﬂammatory
cytokine production in splenic macrophages obtained from
y o u n ga g e dW Ta n dI L - 6K Om i c e .M a c r o p h a g e sf r o ma g e d
and young mice produced proinﬂammatory cytokines upon
LPS stimulation (Figures 1(a)–1(d)). As previously reported
[15–19], macrophages from aged WT mice had decreased
production of TNFα and IL-6 (55%), as well as IL-1β (80%)
and IL-12 (35%) relative to splenic macrophages obtained
f r o my o u n gW Tm i c eg i v e nL P S .S i m i l a rt om a c r o p h a g e s
from aged WT mice, the production of cytokines by
macrophages from young IL-6 KO mice was reduced for
TNFα (67%), IL-1β (31%), and IL-12 (71%) relative to that
of young WT mice (Figure 1). In contrast, as compared
to macrophages from young IL-6 KO mice, LPS exposure
induced higher cytokine production by cells from aged IL-
6 KO mice (1.3, 2.2 and 1.2-fold for TNFα,I L - 1 β and IL-12,
resp.) (Figure 1). Cytokine production by macrophages from
agedIL-6KOmicewaselevatedwhencomparedtocellsfrom
aged WT mice (1.8, 3.7 and 1.9-fold for TNFα,I L - 1 β and IL-
12, resp.). Overall, these results show that IL-6 plays a role
in regulating the age-related defects in macrophages through
alteration of the production of proinﬂammatory cytokines.
3.2. Eﬀects of Age and IL-6 on Splenocyte Cell Populations.
Interleukin-6 is a pleiotropic cytokine, which has an impor-
tant role in supporting the growth of T and B lymphocytes
[30] in lymphoid tissues, mainly in the spleen [31]. There-
fore, lack of expression of IL-6 could modify the phenotype
of splenocytes and their production of cytokines when
cultured in vitro. To test this hypothesis, total spleen cell
suspensions were examined by ﬂow cytometry for speciﬁc
splenocyte cell populations. The percentage of T cells was
determined by analyzing splenocytes bearing the cell surface
markers CD3 (T cells), CD4 (CD3+/CD4+; helper/inducer
cells), and CD8 (CD3+/CD8+; suppressor/cytotoxic cells).
RelativetoyoungWTmice,thepercentageofCD3+ Tc ellsin
splenocytes from aged WT mice was reduced (13%, P<. 05),
Table 1. Interestingly, this diﬀerence was more pronounced
in splenocytes from aged IL-6 KO mice relative to cells from
y o u n gI L - 6K Om i c e( 2 4 %r e d u c t i o ni nC D 3 + T cells, P<
.001). An analysis of splenic CD3+/CD4+ helper/inducer T
cells revealed no eﬀects of aging or IL-6 on their percentage.
However, CD3+/CD8+ suppressor/cytotoxic T cells were
reduced in splenocytes from aged WT mice (25%, P<. 05),
relative to young WT mice. In addition, a marked (47%)
decrease in CD3+/CD8+ suppressor/cytotoxic T cells was
found in aged IL-6 KO animals, relative to splenocytes from
young IL-6 KO mice. Analysis of B cell percentages in the
spleen was also assessed by measuring B220+ splenocytes,
Table 1. Spleens of young WT mice were composed of 40%
B220+cells. This percentage was slightly increased by aging
and IL-6 deﬁciency, however, these diﬀerences failed to
reach statistical signiﬁcance. Similarly, analysis of the F4/80+
macrophage population showed no eﬀects of aging or IL-6
deﬁciency on their percentage.
3.3. Eﬀects of Age and IL-6 on TLR4 Expression in Macropha-
ges. TLR4 involvement in age-related defects in macrophage
activation following LPS activation has been documented
extensively (reviewed in [1, 2]). However, TLR4 levels in
the context of aging and IL-6 deﬁciency are unknown.
To analyze the expression of TLR4 in macrophages from
aged IL-6 KO mice, splenic macrophages were examined
by ﬂow cytometry. As we reported previously [16, 17],
F4/80+ macrophages from aged WT mice did not exhibit
age-associateddiﬀerencesinsurfaceTLR4expression(23.0%
in young WT and 24.7% in aged WT), Table 2. In F4/80+
macrophages from IL-6 KO mice, a similar percentage of
TLR4+ cells was found relative to those from WT mice,
regardless of age or IL-6 deﬁciency (24.6% in young IL-6
KO versus 23.6% in aged IL-6 KO). These results suggest
that changes in TLR4 expression in macrophages are not
responsible for the increase in proinﬂammatory cytokine
production observed in macrophages from aged IL-6 KO
mice.
3.4. Eﬀects of Age and IL-6 on IL-6 Receptor Expression in
Macrophages. In vivo as well as in vitro studies suggest
that stimulation with IL-6 aﬀects the expression of the IL-
6r e c e p t o r[ 32, 33]. To analyze the eﬀects of aging and IL-6
on the initial steps of IL-6 signaling, we measured surface
levels of the IL-6 receptor in total spleen cell suspensions
by ﬂow cytometry. IL-6 signaling is initiated by binding
of the cytokine to an 80-kDa glycoprotein α chain (IL-
6Ra/CD126) [34]. F4/80+ macrophages from aged WT mice
did not diﬀer in the percentage of IL-6Ra expressing cells
(Table 2)orthelevelofthesurfaceexpressionasmeasuredby
mean ﬂuorescent intensity (MFI) (data not shown) relative
to those from young WT mice. In F4/80+ macrophages
from IL-6 KO mice, similar levels of IL-6Ra were found4 Mediators of Inﬂammation
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Figure 1: Splenic macrophages obtained from young and aged WT and IL-6 KO mice were cultured for 18 hours with LPS (100ng/ml).
Supernatants collected were assayed for TNFα (a), IL-1β (b), IL-6 (c), and IL-12 (d), by ELISA. Data are shown as mean ± SEM of 4-5 mice
per group. ∗P<. 05 from young WT. #P <. 05 from young WT. †P<. 05 from young IL-6 KO. @P<. 05 from aged WT.
Table 1: Eﬀects of age and IL-6 on splenocyte cell populations.
Cells (%)
WT IL-6 KO
Young Aged Young Aged
CD3+ TC e l l s 4 7 .1 ±1.14 1 .1 ±1.1
∗ 48.3 ±1.13 6 .9 ± 0.9
∗
CD3+/CD4+ TC e l l s 3 4 .1 ±0.93 1 .0 ±0.83 2 .9 ±0.83 0 .1 ±1.7
CD3+/CD8+TC e l l s 1 3 .6 ±0.91 0 .2 ±0.7
∗ 16.6 ±0.4
∗∗ 8.8 ±0.2
∗
Ly49c+NK Cells 5.4 ±0.14 .2 ±0.3
∗ 5.4 ± 0.24 .1 ±0.2
∗
F4/80+Macrophages 15.9 ±2.11 2 .6 ±1.21 4 .1 ±2.31 3 .3 ±0.9
CD19+Bc e l l s 4 1 .1 ±1.54 3 .4 ±1.24 3 .6 ±2.34 6 .9 ±0.9
Splenocytes were incubated with anti-CD3, CD4, CD8, Ly49c, F4/80, or CD19 antibodies and analyzed by ﬂow cytometry. Data are shown as mean ± SEM
of 4-5 mice per group. ∗P<. 05 from aged matched control. ∗∗P<. 05 from young WT.
Table 2: Percentage of TLR4
+, IL-6Ra
+,a n dGp130
+ in F4/80
+ splenocytes.
F4/80+ cells (%)
WT IL-6 KO
Young Aged Young Aged
TLR4+ 23.0 ±2.82 4 .7 ±1.72 4 .6 ±2.52 3 .6 ±0.4
IL-6Ra+ 61.4 ±1.36 0 .1 ±1.55 9 .1 ±1.16 0 .2 ±2.2
gp130+ 35.6 ±6.32 7 .2 ±2.02 9 .9 ±4.13 1 .2 ±2.4
Splenocytes were incubated with anti-F4/80 and anti-TLR4 antibodies or with anti-F4/80, anti IL-6Ra, and anti-Gp130 antibodies and analyzed by ﬂow
cytometry. Data are shown as mean ± SEM of 4-5 mice per group.Mediators of Inﬂammation 5
relative to those from WT mice, regardless of age or IL-6
deﬁciency.FollowingbindingofIL-6toIL-6Ra,dimerization
of signal-transducing glycoprotein 130 (gp130/CD130) leads
to activation of the Janus kinase (JAK)/signal transducer
and activator of transcription (STAT) 3 signal transduction
pathway. As shown in Table 2, gp130 levels on F4/80+
macrophages from young or aged WT mice were similar. No
eﬀects of aging or IL-6 were found in surface expression of
gp130 in cells from IL-6 KO mice.
4. Discussion
In this report, we analyzed the eﬀects of aging and IL-6 on
cytokine production by macrophages in vitro. Our results
add to published data [15–19] showing decreased synthesis
and release of the proinﬂammatory cytokines, TNFα,I L -
1β, IL-6, and IL-12, in macrophages from aged WT mice
compared to those from young WT animals after LPS
stimulation. In addition, we have found for the ﬁrst time
that knocking out IL-6 restores proinﬂammatory cytokine
production by macrophages from aged mice to the levels
of macrophages from young WT mice. When compared
to aged WT mice, splenocytes from aged IL-6 KO mice
had similar age-related decreases in the relative abundance
of CD3+ T cells, CD3+/CD4+ T cells, and Ly49c+ NK
cells, however, a more pronounced decrease was found in
CD3+/CD8+ T cells. No eﬀects of aging or IL-6 deﬁciency
were found on the percentage of F4/80+ macrophages and
CD19+ B cell populations, neither in the surface expression
of TLR4, nor the components of the IL-6 receptor, IL-6Ra,
and gp130. Overall, our results indicate that IL-6 plays a
role in regulating the age-related defects in macrophages
throughalterationofproinﬂammatorycytokines.Additional
investigation is needed to clarify the cellular mechanisms
involved in such eﬀects.
Macrophages show the impact of advanced aged in many
of their biological properties including cytokine production
(recently reviewed in [1, 2]). In general, when cultured
in vitro with LPS, macrophages from aged mice produce
lower levels of proinﬂammatory cytokines than comparably
stimulated cells from young mice [15–19]. As previously
reported, compared to macrophages from young WT mice,
macrophages from aged WT mice had decreased production
of TNFα and IL-6. IL-1β and IL-12 production after LPS
stimulation also was reduced in macrophages from aged WT
mice. These results are coincident with ﬁndings from Chel-
varajan and collaborators and are independent of the source
usedtoisolatethemacrophages(plasticadherenceutilizedin
current study versus positive selection from unfractionated
splenocytes using magnetic sorting with CD11b microbeads
used by Chelvarajan and collaborators [18]). Overall, our
ﬁndings agree with published literature in demonstrating
decreased cytokine production in macrophages from aged
WT mice.
Interleukin-6 deﬁciency in aged mice restored the
cytokine production proﬁle of macrophages to that of
young WT mice. Age-related alterations in the function
of macrophages result from the combination of intrinsic
and extrinsic defects and possibly the consequence of the
complex interactions with other cell types or the aged
milieu [22]. Our results, added to the previous ﬁndings
[24, 25, 35–37], suggest that altered production of cytokines
in macrophages from aged mice results in part from changes
in the expression of extrinsic factors. Cells from young IL-
6 KO mice had signiﬁcantly lower levels of IL-1β,T N F α,
and IL-12 when incubated with LPS relative to their WT
counterparts. We still don’t have an explanation for these
results, however, it can be speculated that a modiﬁcation in
the steady-state of components of cellular pathways shared
between the IL-6 signaling cascade and proinﬂammatory
cytokine expression (i.e., Erk and AP-1) may be a suitable
common link. Additional studies will clarify this issue.
Interleukin-6 supports the growth of splenic T and B
lymphocytes [30, 31]. It was therefore our interest to study
if the eﬀects of aging and the lack of IL-6 in cytokine
production by macrophages could be attributed to changes
in the numbers of these cells in the spleen. While some
of the splenocyte populations we tested showed age-related
decreasesincytokinerelease,regardlessofthepresenceofIL-
6, we failed to ﬁnd changes for F4/80+ macrophages between
young WT mice and young IL-6 KO mice. Unexpectedly,
am o r ep r o n o u n c e dd e c r e a s ew a sf o u n di nC D 3 +/CD8+
T cells (25% in aged WT versus 47% in aged IL-6 KO,
P<. 05). Our results agree with those from Kopf and
collaborators indicating no eﬀects of IL-6 deﬁciency on the
B cell compartment in the bone marrow and spleen of
young IL-6 KO mice, with normal expression of B220, IgM,
IgD, and CD23 [38]. In this same study the expression of
the T cell receptor α, β, γ, δ chains, CD4, CD8, CD44
(Pgpl), and CD24 (HSA) in splenocytes from young IL-6
KO mice was unchanged [38]. Kopf et al. also reported a
30% to 50% reduction in the total number of splenocytes
in young IL-6 KO mice compared to young controls [38].
Similarly, we observed a 40% reduction in the number
of splenocytes in young IL-6 KO mice as well as in their
concanavalin-A induced proliferative response relative to
young WT mice (data not shown). Overall, these results
stress the involvement of IL-6 in the expansion and function
of speciﬁc lymphoid cell subsets. Further investigation will
help to clarify the eﬀects of IL-6 on some of the age-related T
cell defects, such as lymphocyte activation.
The impact of aging on cell signaling in macrophages has
been analyzed by several groups (reviewed in [39]). Renshaw
and collaborators linked defective production of cytokines
in macrophages from aged mice following LPS stimulation
t oad e c l i n ei na l ls u b c l a s s e so fm R N Af o rT L R sa sw e l l
as decreased surface expression of TLR4 on cells from the
aged mice when compared with those from young mice [15].
However, two independent studies from separate groups
failed to show age-dependent diﬀerences in cell-surface
expression of TLR4 [16, 18]. In our study, we showed similar
surface expression of TLR4 in macrophages from aged WT
mice [16, 18]. TLR4 expression was not aﬀected by either
aging or lack of IL-6 in macrophages from senescent IL-6 KO
mice. Previously, we reported that aged IL-6 KO mice had
similar serum levels of lipopolysaccharide-binding protein
(LPB) relative to aged WT mice [10]. Neither advanced age
norIL-6deﬁciencymodiﬁedtheabilitytoinduceproduction6 Mediators of Inﬂammation
of this protein in vivo after an inﬂammatory challenge
[10]. Therefore, age or IL-6 deﬁciency does not appear to
aﬀect surface expression of the initial molecules involved
in LPS signal transduction. This conclusion also seems to
be valid for the components of the IL-6 receptor whose
levels remained unchanged in macrophages regardless of
age or lack of IL-6. In humans, there was a signiﬁcant
increase of soluble IL-6 receptor until around age 70 and
a gradual decline in its levels after age 70 [40]. In mice,
administration of IL-6 triggered an upregulation of the
components of the IL-6 receptor in several tissues in mice
embryos early during their development [32].However,aged
MRL/lpr mice, genetically predisposed to the development
of autoimmune diseases and reported to have elevated levels
of IL-6 and sIL-6R levels, had a marked downregulation of
gp130 in splenic T cells [33]. Our ﬁndings diﬀer from the
published literature and suggest that up or downregulation
in expression of the IL-6 receptor seen in other models is
unlikely to operate in macrophages when IL-6 is “chronically
absent” and maybe alternative compensatory mechanisms
are operating in cells from aged IL-6 KO mice. Most likely
in our aged IL-6 KO mice, the mechanisms responsible for
age-dependent eﬀects of IL-6 in LPS-mediated cell activation
observed in macrophages may originate at the intracellular
level, such as that which has been observed in macrophages
from aged WT mice. Examples of this may include defects in
intracellular activation cascades [15–17, 41].
There is only a handful of publications on the eﬀects
of IL-6 and aging on speciﬁc cell types involved in inﬂam-
matory responses. Most of the work has been performed in
mouse models of systemic inﬂammatory responses following
burn injury, during sepsis, or after LPS administration.
In one of these studies, we analyzed the eﬀects of aging
and IL-6 on the hepatic inﬂammatory response in two
models of systemic injury: dorsal scald (burn) injury versus
intraperitoneal LPS administration. Evidence obtained from
histological observation showed comparable numbers of
polymorphonuclear cells (PMNs) in the livers of burn-
injured mice regardless of age or IL-6 deﬁciency. However,
increased hepatic neutrophils were seen in aged wild type
(WT) mice given LPS relative to young WT mice given
LPS. Accumulation of hepatic PMNs was drastically reduced
in aged IL-6 KO mice given LPS as compared with LPS-
exposed aged WT mice. These results suggest a role of PMNs
in the—insult speciﬁc—hepatic injury mediated by IL-6 in
aged animals [11]. Starr and collaborators examined the
expression of IL-6 in various tissues in aged WT mice during
LPS-induced systemic inﬂammation. Among the diﬀerent
tissues tested, white adipose tissue from epididymal fat pad
expressed the highest level of IL-6 mRNA in both young and
aged mice with a 5.5-fold higher level in the aged. Immuno-
histochemistry revealed that LPS-induced IL-6 expression
was associated to both the adipocytes and stromal cells. Aged
IL-6 KO mice exhibited reduced mortality to LPS suggesting
ad e l e t e r i o u se ﬀect of IL-6 overexpression in the aged [12].
These results suggest that increased vulnerability to systemic
inﬂammation with age is due in part to augmented IL-6
production by the adipose tissue. Overall, a role for other
cells, besides macrophages, in work documenting advanced
age and IL-6 in vivo is suggested by the two publications
showed above [11, 12]. This report is the ﬁrst to analyze
the eﬀects of aging and IL-6 on cytokine production in
macrophages in vitro. Additional research will clarify the
cellular mechanisms involved in our ﬁndings as well as the
eﬀects of aging and IL-6 on other cell types.
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